{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-006521","form_type":"8-K","ticker":"ZSQR","cik":"0001759186","company_name":"Z Squared Inc.","filed_at":"2024-09-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.433852+00:00","generated_at":"2026-05-31T03:40:54.317775+00:00","sec_items":["3.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Coeptis Therapeutics gets Nasdaq extension to Jan 15, 2025 to regain $1 bid price compliance","bullets":["Nasdaq Hearings Panel granted continued listing through Jan 15, 2025, subject to compliance with Minimum Bid Price Requirement.","Company plans to implement a reverse stock split to regain compliance.","Original non-compliance notice received Jan 29, 2024; previous compliance period ended July 29, 2024.","CEO Dave Mehalick expressed optimism about regaining and maintaining Nasdaq listing.","Extension follows a hearing on Sep 12, 2024; company had appealed earlier delisting determination."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-006521","json":"https://secwatch.observer/filing/0001683168-24-006521.json","markdown":"https://secwatch.observer/filing/0001683168-24-006521.md","text":"https://secwatch.observer/filing/0001683168-24-006521.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1759186/000168316824006521/0001683168-24-006521-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1759186/000168316824006521/coeptis_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T03:40:54.317775+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}